Nav: Home

New network launched to address diabetes complications

March 31, 2016

TORONTO, ON - A new national research network was launched today to transform the health outcomes of individuals with diabetes and its related complications. It will be led by two of Canada's top researchers in the field and includes researchers conducting leading-edge health and biomedical research at nine institutions across the country.

"Diabetes is a huge burden to our health system right now. One in four Canadians have diabetes or pre-diabetes and it's costing us $16-billion per year to treat. By 2020, we anticipate that more than 3 million Canadians will have diabetes. We have an opportunity to harness the tremendous research being done in Canada to find better solutions," said Professor Gary Lewis, Director of the Banting & Best Diabetes Centre at the University of Toronto and a Senior Scientist with the University Health Network.

Lewis will lead the new Strategy for Patient-Oriented Research (SPOR) Network in Diabetes and Related Complications - with Professor Jean-Pierre Després, Scientific Director of the Cardiology Division of the Quebec Heart and Lung institute, Director of Science and Innovation at Alliance santé Québec and a Professor of Kinesiology at Université Laval.

Today, Federal Health Minister Jane Philpott announced funding from the Canadian Institutes for Health Research (CIHR) for five SPOR Networks in Chronic Disease. "These networks will produce the innovations that improve health of Canadians and position Canada as a global leader in research on these chronic diseases," said CIHR President Dr. Alain Beaudet.

Each SPOR Network will receive $12.45-million from CIHR to be matched by partners. The SPOR Network in Diabetes and Related Complications has partnered with the Canadian Diabetes Association, JDRF, the Michael Smith Foundation for Health Research, Research Manitoba, Alliance santé Quebec, New Brunswick Health Research Foundation, as well as private sector contributors including Merck Canada Inc., Astra-Zeneca Inc., Caprion Proteome Inc., and WinSanTor Inc., for a total five-year investment of an additional $19-million for the SPOR Network in Diabetes and Related Complications.

"JDRF is proud to be a SPOR partner, as we greatly value Canadian researchers working collaboratively to accelerate diabetes research. This gives patients hope for a better world, a world without type 1 diabetes (T1D) and this research will move us there faster," said Dave Prowten, President and CEO of JDRF Canada.

"Our network will facilitate meaningful connections between primary healthcare providers, their patients and relevant specialists to achieve improved care and significant cost savings within our health system," said Després.

"I have been living with T1D for 49 years, and have experienced how devastating diabetic related complications can be; I lost my eyesight 25 years ago. Last week my 14-year-old nephew was diagnosed with T1D. This disease continues its devastating path, which is what compels me to fight back and be a member of this SPOR Network," said patient advocate Debbie Sissmore. "I am delighted to represent and advocate for the Canadians that need help in the prevention and treatment of diabetes related complications."

A focus for the network will be the impact diabetes has on vulnerable groups, including Indigenous peoples, immigrants, women and lower socio-economic groups. "We know that diabetes has a disproportionate impact on these groups, but there is still much more research to be done on why and how to deliver appropriate and culturally sensitive treatments," said Lewis.

The network will be based in Toronto at the University Health Network and University of Toronto. The other partner organizations are Université de Sherbrooke, Université Laval, Université de Montréal, University of Alberta, University of British Columbia, University of Manitoba, and the University of New Brunswick.

You can learn more about the SPOR Network in Diabetes by visiting their website: http://www.SPORNetworkDiabetes.ca
-end-
For more information:

Liam Mitchell
Associate Director, Communications
Faculty of Medicine, University of Toronto
Tel: 416-978-4672
Email: liam.mitchell@utoronto.ca

University of Toronto

Related Diabetes Articles:

The role of vitamin A in diabetes
There has been no known link between diabetes and vitamin A -- until now.
Can continuous glucose monitoring improve diabetes control in patients with type 1 diabetes who inject insulin
Two studies in the Jan. 24/31 issue of JAMA find that use of a sensor implanted under the skin that continuously monitors glucose levels resulted in improved levels in patients with type 1 diabetes who inject insulin multiple times a day, compared to conventional treatment.
Complications of type 2 diabetes affect quality of life, care can lead to diabetes burnout
T2D Lifestyle, a national survey by Health Union of more than 400 individuals experiencing type 2 diabetes (T2D), reveals that patients not only struggle with commonly understood complications, but also numerous lesser known ones that people do not associate with diabetes.
Type 2 diabetes and obesity -- what do we really know?
Social and economic factors have led to a dramatic rise in type 2 diabetes and obesity around the world.
A better way to predict diabetes
An international team of researchers has discovered a simple, accurate new way to predict which women with gestational diabetes will develop type 2 diabetes after delivery.
The Lancet Diabetes & Endocrinology: Older Americans with diabetes living longer without disability, US study shows
Older Americans with diabetes born in the 1940s are living longer and with less disability performing day to day tasks than those born 10 years earlier, according to new research published in The Lancet Diabetes & Endocrinology journal.
Reverse your diabetes -- and you can stay diabetes-free long-term
A new study from Newcastle University, UK, has shown that people who reverse their diabetes and then keep their weight down remain free of diabetes.
New cause of diabetes
Although insulin-producing cells are found in the endocrine tissue of the pancreas, a new mouse study suggests that abnormalities in the exocrine tissue could cause cell non-autonomous effects that promotes diabetes-like symptoms.
The Lancet Diabetes & Endocrinology: Reducing sugar content in sugar-sweetened drinks by 40 percent over 5 years could prevent 1.5 million cases of overweight and obesity in the UK and 300,000 cases of diabetes
A new study published in The Lancet Diabetes & Endocrinology journal suggests that reducing sugar content in sugar sweetened drinks (including fruit juices) in the UK by 40 percent over five years, without replacing them with any artificial sweeteners, could prevent 500,000 cases of overweight and 1 million cases of obesity, in turn preventing around 300,000 cases of type 2 diabetes, over two decades.
Breastfeeding lowers risk of type 2 diabetes following gestational diabetes
Women with gestational diabetes who consistently and continuously breastfeed from the time of giving birth are half as likely to develop type 2 diabetes within two years after delivery, according to a study from Kaiser Permanente published today in Annals of Internal Medicine.

Related Diabetes Reading:

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Moving Forward
When the life you've built slips out of your grasp, you're often told it's best to move on. But is that true? Instead of forgetting the past, TED speakers describe how we can move forward with it. Guests include writers Nora McInerny and Suleika Jaouad, and human rights advocate Lindy Lou Isonhood.
Now Playing: Science for the People

#527 Honey I CRISPR'd the Kids
This week we're coming to you from Awesome Con in Washington, D.C. There, host Bethany Brookshire led a panel of three amazing guests to talk about the promise and perils of CRISPR, and what happens now that CRISPR babies have (maybe?) been born. Featuring science writer Tina Saey, molecular biologist Anne Simon, and bioethicist Alan Regenberg. A Nobel Prize winner argues banning CRISPR babies won’t work Geneticists push for a 5-year global ban on gene-edited babies A CRISPR spin-off causes unintended typos in DNA News of the first gene-edited babies ignited a firestorm The researcher who created CRISPR twins defends...